Culp William T N, Olea-Popelka Francisco, Sefton Jennifer, Aldridge Charles F, Withrow Stephen J, Lafferty Mary H, Rebhun Robert B, Kent Michael S, Ehrhart Nicole
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.
J Am Vet Med Assoc. 2014 Nov 15;245(10):1141-6. doi: 10.2460/javma.245.10.1141.
To evaluate clinical characteristics, outcome, and prognostic variables in a cohort of dogs surviving > 1 year after an initial diagnosis of osteosarcoma.
Retrospective case series.
90 client-owned dogs.
Medical records for an 11-year period from 1997 through 2008 were reviewed, and patients with appendicular osteosarcoma that lived > 1 year after initial histopathologic diagnosis were studied. Variables including signalment, weight, serum alkaline phosphatase activity, tumor location, surgery, and adjuvant therapies were recorded. Median survival times were calculated by means of a Kaplan-Meier survival function. Univariate analysis was conducted to compare the survival function for categorical variables, and the Cox proportional hazard model was used to evaluate the likelihood of death > 1 year after diagnosis on the basis of the selected risk factors.
90 dogs met the inclusion criteria; clinical laboratory information was not available in all cases. Median age was 8.2 years (range, 2.7 to 13.3 years), and median weight was 38 kg (83.6 lb; range, 21 to 80 kg [46.2 to 176 lb]). Serum alkaline phosphatase activity was high in 29 of 60 (48%) dogs. The most common tumor location was the distal portion of the radius (54/90 [60%]). Eighty-nine of 90 (99%) dogs underwent surgery, and 78 (87%) received chemotherapy. Overall, 49 of 90 (54%) dogs developed metastatic disease. The median survival time beyond 1 year was 243 days (range, 1 to 1,899 days). Dogs that developed a surgical-site infection after limb-sparing surgery had a significantly improved prognosis > 1 year after osteosarcoma diagnosis, compared with dogs that did not develop infections.
Results of the present study indicated that dogs with an initial diagnosis of osteosarcoma that lived > 1 year had a median survival time beyond the initial year of approximately 8 months. As reported previously, the development of a surgical-site infection in dogs undergoing a limb-sparing surgery significantly affected prognosis and warrants further study.
评估一组初次诊断骨肉瘤后存活超过1年的犬只的临床特征、结局及预后变量。
回顾性病例系列研究。
90只客户拥有的犬只。
回顾1997年至2008年11年间的病历,研究初次组织病理学诊断后存活超过1年的四肢骨肉瘤患者。记录包括特征、体重、血清碱性磷酸酶活性、肿瘤位置、手术及辅助治疗等变量。通过Kaplan-Meier生存函数计算中位生存时间。进行单因素分析以比较分类变量的生存函数,并使用Cox比例风险模型根据选定的风险因素评估诊断后超过1年死亡的可能性。
90只犬符合纳入标准;并非所有病例都有临床实验室信息。中位年龄为8.2岁(范围2.7至13.3岁),中位体重为38千克(83.6磅;范围21至80千克[46.2至176磅])。60只犬中有29只(48%)血清碱性磷酸酶活性升高。最常见的肿瘤位置是桡骨远端(54/90 [60%])。90只犬中有89只(99%)接受了手术,78只(87%)接受了化疗。总体而言,90只犬中有49只(54%)发生了转移性疾病。超过1年的中位生存时间为243天(范围1至1899天)。与未发生感染的犬相比,保肢手术后发生手术部位感染的犬在骨肉瘤诊断后超过1年的预后有显著改善。
本研究结果表明,初次诊断骨肉瘤后存活超过1年的犬,初始年份后的中位生存时间约为8个月。如先前报道,接受保肢手术的犬发生手术部位感染显著影响预后,值得进一步研究。